Hel­lo, neffy: FDA ap­proves first nasal spray for se­vere al­ler­gic re­ac­tions

Over the last 40 years, twin packs of EpiPens be­came a fix­ture for peo­ple and par­ents with chil­dren ex­pe­ri­enc­ing se­vere al­ler­gic re­ac­tions.

Now, ARS Phar­ma­ceu­ti­cals …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.